Method for detecting pancreatic cancer
We are happy to share with you great news – our innovative method for early detection of pancreatic cancer was successfully patented in the United States of America in March! This significant milestone is the result of an almost five-year process, during which it underwent a thorough assessment by the US patent offices.
The patent applies to our diagnostic method, which enables the detection of pancreatic cancer using the analysis of lipids from blood. A detailed description of the method on 75 pages confirms its scientific and clinical value.
Obtaining a US patent significantly advances the potential of using screening tests and complements patents granted in the EU, Japan and Singapore.
